Form 4 for CYTK CYTOKINETICS INC
Accepted 2024-05-07 00:00:00 ET · period of report 2024-05-07 · accession 0001127602-24-014445 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-07 | 2024-05-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $6.67 | +14.2K | 152.6K | +10% | +$94.6K |
| DM | 2024-05-07 | 2024-05-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $65.11 | -15.5K | 137.1K | -10% | -$1.01M |
| D | 2024-05-07 | 2024-05-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $0.00 | -14.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-07 | M | A | 14,186 | $6.67 | 152,603 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-07 | S | D | 14,186 | $65.11 | 138,417 | D | — | — | |
| 3 | Common | Common Stock | 2024-05-07 | S | D | 1,361 | $65.11 | 137,056 | D | — | — | |
| 4 | Derivative | Incentive Stock Option (Right to Buy) | 2024-05-07 | M | D | 14,186 | $0.00 | 0 | D | $6.67 · 2016-03-23 to 2026-02-23 | 14,186 Common Stock |